Medplus Health Services has informed that Optival Health Solutions, a subsidiary of the company has received four suspension orders of Drug License for store situated at location as mentioned below. Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 read with SEBI Circular SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024, the details of the matter are enclosed.
The above information is a part of company’s filings submitted to BSE.